Market Overview:
The global prefilled needle-free injector market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic diseases, rising demand for minimally invasive procedures, and technological advancements in prefilled needle-free injectors. Based on type, the global prefilled needle-free injector market is segmented into reusable and disposable types. The disposable type is expected to account for a larger share of the market than the reusable type during the forecast period. This can be attributed to factors such as ease of use and disposal, lower cost, and increasing preference for disposables over reusables among healthcare providers. Based on application, the global prefilled needle-free injector market is segmented into hospital care settings, clinic care settings, and other applications (including research laboratories and homecare settings). The hospital care setting segment is expected to account for a larger share of the market than other application segments duringthe forecast period owingto rising demandfor minimally invasive proceduresand growing numberof hospitals worldwide.
Product Definition:
A prefilled needle-free injector is a medical device that is used to inject medication or other fluids into the body without the use of a needle. The prefilled needle-free injector is an important medical device because it can help to reduce the risk of infection and other complications that can occur when using a needle.
Reusable:
Reusable injection devices are used by healthcare professionals to deliver medications to patients. They are majorly used in the treatment of diabetes, anaphylaxis, and asthma. The global reusable needle-free injector market is expected to witness significant growth over the forecast period owing to factors such as increasing prevalence of these diseases and high demand for cost-effective drugs.
Disposable:
The global disposable and it’s usage in Prefilled Needle-Free Injector (PNFI) market size was valued at USD 5.5 billion in 2018 and is expected to grow at a compound annual growth rate (CAGR) of7.1% from 2019 to 2025.
Application Insights:
The hospital application segment dominated the global prefilled needle-free injector market in 2017, accounting for over 60.0% share of the total revenue. The growing prevalence of chronic diseases such as cancer and cardiovascular diseases is expected to drive demand for PNFI in hospitals during the forecast period. Moreover, an increase in healthcare spending by governments as well as private organizations is anticipated to further fuel demand for these devices over the next eight years.
Clinical settings include clinics and other medical facilities that provide primary care services such as family medicine, internal medicine, pediatrics etc., These settings require a lower number of PNFI due to their low complexity and cost savings obtained by not using reusable devices or syringes among other factors driving its growth at a significant rate during this period.
Regional Analysis:
North America dominated the global market in 2017. The presence of sophisticated healthcare infrastructure, high awareness among people about immunization programs, and favorable government initiatives are some of the major factors responsible for its large share. Moreover, increasing R&D investments by pharmaceutical companies to develop novel prefilled needle-free injectors is expected to drive growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising demand for immunization programs and increasing target population base due to growing population and expanding urban areas in this region. In addition, a rise in chronic diseases such as diabetes that require regular injections will boost product demand further driving revenue generation from prefilled needle-free injector market over next eight years.
Growth Factors:
- Increasing prevalence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyles and dietary habits of people across the world. Prefilled needle-free injectors can help in the treatment of various chronic diseases such as diabetes, cancer, and arthritis.
- Technological advancements: The technology used in prefilled needle-free injectors is constantly evolving, which is resulting in better performance and user experience. This is encouraging more people to adopt these devices for their personal use or for use by healthcare professionals.
- Rising demand for self-injection therapies: There has been a rise in the demand for self-injection therapies due to factors such as increased patient awareness about treatments available, growing number of lifestyle diseases, and rising costs associated with traditional drug delivery methods such as intravenous injections or syringes & needles . Prefilled needle-free injectors offer an efficient and convenient alternative to these traditional methods, thereby contributing to their growth prospects .
Scope Of The Report
Report Attributes
Report Details
Report Title
Prefilled Needle-Free Injector Market Research Report
By Type
Reusable, Disposable
By Application
Hospital, Clinic, Others
By Companies
Antares Pharma Inc, Endo International, Pharma Jet, Bioject Medical Technologies, Medical International Technology Inc, INJEX Pharama AG, National Medical Products Inc, Valeritas Inc, European Pharma Group, PenJet Corporation, Crossject SA
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Prefilled Needle-Free Injector Market Report Segments:
The global Prefilled Needle-Free Injector market is segmented on the basis of:
Types
Reusable, Disposable
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Antares Pharma Inc
- Endo International
- Pharma Jet
- Bioject Medical Technologies
- Medical International Technology Inc
- INJEX Pharama AG
- National Medical Products Inc
- Valeritas Inc
- European Pharma Group
- PenJet Corporation
- Crossject SA
Highlights of The Prefilled Needle-Free Injector Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Reusable
- Disposable
- By Application:
- Hospital
- Clinic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Prefilled Needle-Free Injector Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A prefilled needle-free injector is a device that uses a cartridge filled with the patient's medication. The user inserts the cartridge into the device, which then dispenses the medication.
Some of the key players operating in the prefilled needle-free injector market are Antares Pharma Inc, Endo International, Pharma Jet, Bioject Medical Technologies, Medical International Technology Inc, INJEX Pharama AG, National Medical Products Inc, Valeritas Inc, European Pharma Group, PenJet Corporation, Crossject SA.
The prefilled needle-free injector market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Prefilled Needle-Free Injector Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Prefilled Needle-Free Injector Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Prefilled Needle-Free Injector Market - Supply Chain
4.5. Global Prefilled Needle-Free Injector Market Forecast
4.5.1. Prefilled Needle-Free Injector Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Prefilled Needle-Free Injector Market Size (000 Units) and Y-o-Y Growth
4.5.3. Prefilled Needle-Free Injector Market Absolute $ Opportunity
5. Global Prefilled Needle-Free Injector Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Prefilled Needle-Free Injector Market Size and Volume Forecast by Type
5.3.1. Reusable
5.3.2. Disposable
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Prefilled Needle-Free Injector Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Prefilled Needle-Free Injector Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Clinic
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Prefilled Needle-Free Injector Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Prefilled Needle-Free Injector Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Prefilled Needle-Free Injector Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Prefilled Needle-Free Injector Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Prefilled Needle-Free Injector Demand Share Forecast, 2019-2026
9. North America Prefilled Needle-Free Injector Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Prefilled Needle-Free Injector Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Prefilled Needle-Free Injector Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Clinic
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Prefilled Needle-Free Injector Market Size and Volume Forecast by Type
9.7.1. Reusable
9.7.2. Disposable
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Prefilled Needle-Free Injector Demand Share Forecast, 2019-2026
10. Latin America Prefilled Needle-Free Injector Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Prefilled Needle-Free Injector Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Prefilled Needle-Free Injector Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Clinic
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Prefilled Needle-Free Injector Market Size and Volume Forecast by Type
10.7.1. Reusable
10.7.2. Disposable
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Prefilled Needle-Free Injector Demand Share Forecast, 2019-2026
11. Europe Prefilled Needle-Free Injector Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Prefilled Needle-Free Injector Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Prefilled Needle-Free Injector Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Clinic
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Prefilled Needle-Free Injector Market Size and Volume Forecast by Type
11.7.1. Reusable
11.7.2. Disposable
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Prefilled Needle-Free Injector Demand Share, 2019-2026
12. Asia Pacific Prefilled Needle-Free Injector Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Prefilled Needle-Free Injector Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Prefilled Needle-Free Injector Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Clinic
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Prefilled Needle-Free Injector Market Size and Volume Forecast by Type
12.7.1. Reusable
12.7.2. Disposable
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Prefilled Needle-Free Injector Demand Share, 2019-2026
13. Middle East & Africa Prefilled Needle-Free Injector Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Prefilled Needle-Free Injector Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Prefilled Needle-Free Injector Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Clinic
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Prefilled Needle-Free Injector Market Size and Volume Forecast by Type
13.7.1. Reusable
13.7.2. Disposable
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Prefilled Needle-Free Injector Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Prefilled Needle-Free Injector Market: Market Share Analysis
14.2. Prefilled Needle-Free Injector Distributors and Customers
14.3. Prefilled Needle-Free Injector Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Antares Pharma Inc
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Endo International
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Pharma Jet
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Bioject Medical Technologies
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Medical International Technology Inc
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. INJEX Pharama AG
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. National Medical Products Inc
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Valeritas Inc
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. European Pharma Group
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. PenJet Corporation
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Crossject SA
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
